Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden.

Alzheimer's disease antiviral agents dementia herpes simplex herpes zoster retrospective cohort study varicella zoster

Journal

Alzheimer's & dementia (New York, N. Y.)
ISSN: 2352-8737
Titre abrégé: Alzheimers Dement (N Y)
Pays: United States
ID NLM: 101650118

Informations de publication

Date de publication:
2021
Historique:
received: 16 10 2020
accepted: 04 11 2020
entrez: 22 2 2021
pubmed: 23 2 2021
medline: 23 2 2021
Statut: epublish

Résumé

Herpesviruses, including Herpes simplex virus type 1 (HSV1) and varicella zoster-virus (VZV), have been implicated in Alzheimer's disease (AD) development. Likewise, antiviral treatment has been suggested to protect against dementia development in herpes-infected individuals. The study enrolled 265,172 subjects aged ≥ 50 years, with diagnoses of VZV or HSV, or prescribed antiviral drugs between 31 December 2005 and 31 December 2017. Controls were matched in a 1:1 ratio by sex and birth year. Antiviral treatment was associated with decreased risk of dementia (adjusted hazard ratio [HR] 0.89, 95% confidence interval [CI] 0.86 to 0.92), while herpes infection without antiviral drugs increased the risk of dementia (adjusted HR 1.50, 95% CI 1.29 to 1.74). Antiviral treatment was associated with a reduced long-term risk of dementia among individuals with overt signs of herpes infection. This is consistent with earlier findings indicating that herpesviruses are involved in the pathogenesis of AD.

Identifiants

pubmed: 33614892
doi: 10.1002/trc2.12119
pii: TRC212119
pmc: PMC7882534
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e12119

Informations de copyright

© 2020 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest.

Références

J Alzheimers Dis. 2018;64(2):363-366
pubmed: 29889070
PLoS One. 2017 Nov 22;12(11):e0188490
pubmed: 29166672
J Clin Virol. 2009 Nov;46(3):249-53
pubmed: 19709927
Alzheimers Dement. 2015 Jun;11(6):587-92
pubmed: 25304990
Lancet. 1997 Jan 25;349(9047):241-4
pubmed: 9014911
J Neurol. 2013 Nov;260(11):2761-9
pubmed: 23900759
Ann Neurol. 2003 Aug;54(2):267-71
pubmed: 12891684
Alzheimers Dement (N Y). 2019 Nov 04;5:697-704
pubmed: 31921962
J Alzheimers Dis. 2018;61(4):1301-1310
pubmed: 29376854
Stat Med. 2009 Feb 1;28(3):389-411
pubmed: 18833567
Immun Ageing. 2017 May 10;14:10
pubmed: 28491117
BMC Geriatr. 2018 Feb 17;18(1):50
pubmed: 29454305
Neuron. 2018 Jul 11;99(1):64-82.e7
pubmed: 29937276
Sci Adv. 2020 May 06;6(19):eaay8828
pubmed: 32494701
Alzheimers Dement. 2015 Jun;11(6):593-9
pubmed: 25043910
Scand J Prim Health Care. 2011 Sep;29(3):181-6
pubmed: 21740344
Sci Transl Med. 2016 May 25;8(340):340ra72
pubmed: 27225182
Eur Arch Psychiatry Clin Neurosci. 2020 Jul 1;:
pubmed: 32613564
Arch Neurol. 2011 Aug;68(8):1049-56
pubmed: 21825242
J Alzheimers Dis. 2015;48(2):319-53
pubmed: 26401998
J Neurol Neurosurg Psychiatry. 1997 Jun;62(6):586-9
pubmed: 9219743
J Infect Dis. 2020 Mar 16;221(7):1088-1097
pubmed: 31665341
PLoS One. 2017 Feb 8;12(2):e0171182
pubmed: 28178287
PLoS Pathog. 2019 Mar 14;15(3):e1007617
pubmed: 30870531
Sex Transm Infect. 2010 Jun;86(3):202-6
pubmed: 20410080
Future Virol. 2012 Sep;7(9):885-899
pubmed: 23335944
Alzheimers Dement. 2020 Jan;16(1):200-208
pubmed: 31914220
J Alzheimers Dis. 2015;47(2):351-64
pubmed: 26401558
Lipids Health Dis. 2010 Jan 28;9:8
pubmed: 20109174
J Clin Psychiatry. 2018 Jan/Feb;79(1):
pubmed: 29244265
Neurotherapeutics. 2018 Apr;15(2):417-429
pubmed: 29488144
PLoS One. 2015 Feb 19;10(2):e0116538
pubmed: 25695768
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
PLoS One. 2008;3(11):e3637
pubmed: 18982063
Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-35
pubmed: 16897791
J Alzheimers Dis. 2019;67(1):211-220
pubmed: 30636735
J Alzheimers Dis. 2016;51(4):979-84
pubmed: 26967229
J Alzheimers Dis. 2018;61(3):939-945
pubmed: 29254081

Auteurs

Karin Lopatko Lindman (K)

Department of Community Medicine and Rehabilitation, Geriatric Medicine Umeå University Umeå Sweden.

Eva-Stina Hemmingsson (ES)

Department of Community Medicine and Rehabilitation, Geriatric Medicine Umeå University Umeå Sweden.

Bodil Weidung (B)

Department of Community Medicine and Rehabilitation, Geriatric Medicine Umeå University Umeå Sweden.
Department of Public Health and Caring Sciences, Geriatric Medicine Uppsala University Uppsala Sweden.

Jon Brännström (J)

Department of Community Medicine and Rehabilitation, Geriatric Medicine Umeå University Umeå Sweden.

Maria Josefsson (M)

Centre for Demographic and Ageing Research Umeå University Umeå Sweden.

Jan Olsson (J)

Department of Clinical Microbiology, Virology Umeå University Umeå Sweden.

Fredrik Elgh (F)

Department of Clinical Microbiology, Virology Umeå University Umeå Sweden.

Peter Nordström (P)

Department of Community Medicine and Rehabilitation, Geriatric Medicine Umeå University Umeå Sweden.

Hugo Lövheim (H)

Department of Community Medicine and Rehabilitation, Geriatric Medicine Umeå University Umeå Sweden.
Wallenberg Centre for Molecular Medicine (WCMM) Umeå University Umeå Sweden.

Classifications MeSH